ArticleVaccines2026

Immunogenicity and Safety of a Full-Dose Regimen of Cell Culture-Derived Quadrivalent Inactivated Influenza Vaccine in Children Aged 6-35 Months: Results from a Multinational Phase 3 Randomised Controlled Trial.

Yoonsun Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.